Published on in Vol 2, No 2 (2018): Jul-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/9935, first published
.
Journals
- Schonberg M, Davis R, Karamourtopoulos M, Pinheiro A, Sternberg S, Jacobson A, Aliberti G, Mehta T, Cluett J, Cohen M, Atlas T, Tung N. A Pre-Test–Post-Test Trial of a Breast Cancer Risk Report for Women in Their 40s. American Journal of Preventive Medicine 2020;59(3):343 View
- Phillips K, Liao Y, Milne R, MacInnis R, Collins I, Buchsbaum R, Weideman P, Bickerstaffe A, Nesci S, Chung W, Southey M, Knight J, Whittemore A, Dite G, Goldgar D, Giles G, Glendon G, Cuzick J, Antoniou A, Andrulis I, John E, Daly M, Buys S, Hopper J, Terry M. Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool. JNCI Cancer Spectrum 2019;3(4) View
- Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French D, Evans D. Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020). Cancers 2020;12(12):3697 View
- Britt K, Cuzick J, Phillips K. Key steps for effective breast cancer prevention. Nature Reviews Cancer 2020;20(8):417 View
- Usher-Smith J, Hindmarch S, French D, Tischkowitz M, Moorthie S, Walter F, Dennison R, Stutzin Donoso F, Archer S, Taylor L, Emery J, Morris S, Easton D, Antoniou A. Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. British Journal of Cancer 2023;128(9):1636 View
- Bellhouse S, Hawkes R, Howell S, Gorman L, French D. Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours. Cancers 2021;13(16):4150 View
- Ganggayah M, Dhillon S, Islam T, Kalhor F, Chiang T, Kalafi E, Taib N. An Artificial Intelligence-Enabled Pipeline for Medical Domain: Malaysian Breast Cancer Survivorship Cohort as a Case Study. Diagnostics 2021;11(8):1492 View
- Xu X, Ge Z, Chow E, Yu Z, Lee D, Wu J, Ong J, Fairley C, Zhang L. A Machine-Learning-Based Risk-Prediction Tool for HIV and Sexually Transmitted Infections Acquisition over the Next 12 Months. Journal of Clinical Medicine 2022;11(7):1818 View
- Fletcher E, Burns A, Wiering B, Lavu D, Shephard E, Hamilton W, Campbell J, Abel G. Workload and workflow implications associated with the use of electronic clinical decision support tools used by health professionals in general practice: a scoping review. BMC Primary Care 2023;24(1) View
- Attieh S, Monarque M, Durand A, Ahmed S, Knoppers B, Simard J, Loiselle C. Perceptions and Usability of PREVENTION: A Breast Cancer Risk Assessment e-Platform. Journal of Personalized Medicine 2023;13(5):850 View
- He W, Chima S, Emery J, Manski-Nankervis J, Williams I, Hunter B, Nelson C, Martinez-Gutierrez J. Perceptions of primary care patients on the use of electronic clinical decision support tools to facilitate health care: A systematic review.. Patient Education and Counseling 2024;125:108290 View
- Riganti P, Ruiz Yanzi M, Escobar Liquitay C, Sgarbossa N, Alarcon-Ruiz C, Kopitowski K, Franco J. Shared decision-making for supporting women’s decisions about breast cancer screening. Cochrane Database of Systematic Reviews 2024;2024(5) View
- McGarrigle S, Prizeman G, Spillane C, Byrne N, Drury A, Polus M, Mockler D, Connolly E, Brady A, Hanhauser Y. Decision aids for female BRCA mutation carriers: a scoping review. BMJ Open 2024;14(6):e076876 View
- Choi Y, Park Y, Park B, Chae H, Jung S, Ryu K, Lim M, Park S, Chang Y, Kong S. Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant. Scientific Reports 2024;14(1) View
- Feufel M, Speiser D, Schüürhuis S, Neumann K, Keinert M, Stegen S, Rauwolf G, Heibges M, Westfal V, Besch L, Olbrich C, Klein K, Witzel I, Kendel F. iKNOW—Supporting the counseling of women with hereditary risk of breast and ovarian cancer with digital technologies: A randomized controlled trial. Genetics in Medicine Open 2024:101892 View